- Home
- RIGL vs OFLX Comparison
RIGL vs OFLX Comparison
Compare RIGL & OFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- OFLX
- Stock Information
- Founded
- RIGL 1996
- OFLX 1975
- Country
- RIGL United States
- OFLX United States
- Employees
- RIGL N/A
- OFLX N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- OFLX Industrial Specialties
- Sector
- RIGL Health Care
- OFLX Industrials
- Exchange
- RIGL Nasdaq
- OFLX Nasdaq
- Market Cap
- RIGL 335.5M
- OFLX 344.9M
- IPO Year
- RIGL 2000
- OFLX 2005
- Fundamental
- Price
- RIGL $18.28
- OFLX $33.87
- Analyst Decision
- RIGL Buy
- OFLX
- Analyst Count
- RIGL 5
- OFLX 0
- Target Price
- RIGL $36.40
- OFLX N/A
- AVG Volume (30 Days)
- RIGL 170.2K
- OFLX 48.9K
- Earning Date
- RIGL 08-05-2025
- OFLX 07-30-2025
- Dividend Yield
- RIGL N/A
- OFLX 4.00%
- EPS Growth
- RIGL N/A
- OFLX N/A
- EPS
- RIGL 2.08
- OFLX 1.72
- Revenue
- RIGL $203,077,000.00
- OFLX $99,795,000.00
- Revenue This Year
- RIGL $14.41
- OFLX N/A
- Revenue Next Year
- RIGL $15.97
- OFLX N/A
- P/E Ratio
- RIGL $8.92
- OFLX $19.46
- Revenue Growth
- RIGL 70.16
- OFLX N/A
- 52 Week Low
- RIGL $7.48
- OFLX $28.12
- 52 Week High
- RIGL $29.82
- OFLX $57.81
- Technical
- Relative Strength Index (RSI)
- RIGL 37.91
- OFLX 57.47
- Support Level
- RIGL $18.35
- OFLX $32.00
- Resistance Level
- RIGL $19.21
- OFLX $34.73
- Average True Range (ATR)
- RIGL 0.89
- OFLX 1.50
- MACD
- RIGL -0.33
- OFLX 0.19
- Stochastic Oscillator
- RIGL 2.15
- OFLX 78.12
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.